P
Phantom Neuro
Creates a system that will enable lifelike control of robotic orthopedic technologies
About Phantom Neuro
Phantom Neuro is a cutting-edge startup that operates in the field of medical technology, specifically in the development of brain-machine interfaces. The company's flagship product, the Phantom X, is a minimally invasive, low-profile implantable sensor designed to detect natural muscle signals. These signals are then wirelessly communicated to an external device for decoding and output. This technology allows users to have complete control over their chosen robotic prosthetic solutions, providing a level of natural control that is unprecedented in orthopedic systems.
The company's business model revolves around the development and sale of these innovative orthopedic devices. Phantom Neuro's primary clients are individuals who require prosthetic solutions, but the technology also has potential applications in other areas of robotics. The company makes money by selling the Phantom X sensors and the accompanying mobile companion app, which provides control training and system optimization.
Phantom Neuro's technology is a significant advancement in the field of robotics, bridging the gap between people and robotic systems. By turning intention into robotic action, the company is revolutionizing human-machine interaction and helping people regain control of their lives.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- Austin, United States
- Employees
- 19
- Open positions
- None listed
- Dealroom signal
- 85.9/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Rehabilitation, Neurology, Core AI, Spinout, Sensor Tech, Autonomous Mobile Robots
- Technology
- Artificial Intelligence, Hardware, Deep Tech, IoT InternetOfThings
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Apr 2025 | $19M | $76M | LionBird · METIS innovative · Actual VC · MainSheet Ventures | ↗ |
| SEED✓Equity / VC | Sep 2022 | $6M | $24M | BlackRock · Draper Associates · Rsquared · LionBird | ↗ |
Growth signals
Latest recorded traffic for Phantom Neuro is 4.3K monthly website visits, up 13.2% over the last three months. Phantom Neuro's team grew 18.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed8 investors entered at this stage
LionBird
Draper Associates
Capital Factory
Breakout Ventures
Blackrock Neurotech
Time BioVentures
BlackRock
Rsquared
Series A7 investors entered at this stage
Ottobock
METIS innovative
Actual VC
MainSheet Ventures
E1 ventures
Jumpspace
Brown Advisory
Other known investors1 additional known investor
Johns Hopkins Technology Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Phantom Neuro on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Phantom Neuro’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.